The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
Volume 352:2571-2573 June 23, 2005 Number 25
NextNext

Marburg and Ebola — Arming Ourselves against the Deadly Filoviruses
C.J. Peters, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Interview

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
As of May 26, 2005, the Angolan Ministry of Health had reported 399 cases of Marburg hemorrhagic fever, 335 of which were fatal. Even as this unprecedented spread of filovirus infection continued, Marburg's sister virus, Ebola, had killed nine people in the Republic of Congo. Although Ebola may now be the better-known sibling, Marburg virus was identified first, in 1967, after an infectious-disease clinician at the university hospital in Marburg, Germany, saw patients with a severe febrile syndrome associated with bleeding from multiple sites on the skin and the mucous membranes and shock. The patients all worked for a pharmaceutical . . . [Full Text of this Article]


Source Information

Dr. Peters is a professor of tropical and emerging virology and the director of biodefense at the Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston.

An interview with Dr. Peters can be heard at www.nejm.org.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.